- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.31 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.1: 13 residues within 4Å:- Chain A: K.35, S.179, E.181, L.231, N.232, N.346, G.348, I.407, Q.408, C.413, V.414, S.415
- Ligands: NAG.11
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.348
NAG-NAG-BMA-MAN-MAN-MAN.19: 13 residues within 4Å:- Chain C: K.35, S.179, E.181, L.231, N.232, N.346, G.348, I.407, Q.408, C.413, V.414, S.415
- Ligands: NAG.29
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:G.348
NAG-NAG-BMA-MAN-MAN-MAN.37: 13 residues within 4Å:- Chain E: K.35, S.179, E.181, L.231, N.232, N.346, G.348, I.407, Q.408, C.413, V.414, S.415
- Ligands: NAG.47
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:G.348
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: V.144, R.162, N.167
- Chain E: R.278
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 6 residues within 4Å:- Chain A: T.267, H.299, N.301, D.380, S.381, T.383
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 4 residues within 4Å:- Chain A: R.278
- Chain C: V.144, R.162, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 6 residues within 4Å:- Chain C: T.267, H.299, N.301, D.380, S.381, T.383
No protein-ligand interaction detected (PLIP)NAG-NAG.38: 4 residues within 4Å:- Chain C: R.278
- Chain E: V.144, R.162, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.39: 6 residues within 4Å:- Chain E: T.267, H.299, N.301, D.380, S.381, T.383
No protein-ligand interaction detected (PLIP)- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 3 residues within 4Å:- Chain A: N.204, T.206, S.244
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.246, T.248, N.249
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: N.308, W.364
Ligand excluded by PLIPNAG.7: 1 residues within 4Å:- Chain A: N.324
Ligand excluded by PLIPNAG.8: 6 residues within 4Å:- Chain A: N.332, S.333, N.355, S.357
- Ligands: NAG.9, NAG.10
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain A: N.355, S.357
- Ligands: NAG.8
Ligand excluded by PLIPNAG.10: 2 residues within 4Å:- Chain A: N.361
- Ligands: NAG.8
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain A: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.1
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain A: N.118, S.120, Y.135
Ligand excluded by PLIPNAG.13: 6 residues within 4Å:- Chain A: T.98, Q.100, S.120, N.122, K.131, K.133
Ligand excluded by PLIPNAG.14: 5 residues within 4Å:- Chain A: Q.263, N.265, V.302, S.303, R.412
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain A: N.271, I.292, V.410
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain B: N.100, S.102
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain B: N.107
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain B: E.123, N.126
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain C: N.204, T.206, S.244
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain C: N.246, T.248, N.249
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain C: N.308, W.364
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain C: N.324
Ligand excluded by PLIPNAG.26: 6 residues within 4Å:- Chain C: N.332, S.333, N.355, S.357
- Ligands: NAG.27, NAG.28
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.355, S.357
- Ligands: NAG.26
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain C: N.361
- Ligands: NAG.26
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain C: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.19
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: N.118, S.120, Y.135
Ligand excluded by PLIPNAG.31: 6 residues within 4Å:- Chain C: T.98, Q.100, S.120, N.122, K.131, K.133
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain C: Q.263, N.265, V.302, S.303, R.412
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain C: N.271, I.292, V.410
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain D: N.100, S.102
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain D: N.107
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain D: E.123, N.126
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain E: N.204, T.206, S.244
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain E: N.246, T.248, N.249
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain E: N.308, W.364
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain E: N.324
Ligand excluded by PLIPNAG.44: 6 residues within 4Å:- Chain E: N.332, S.333, N.355, S.357
- Ligands: NAG.45, NAG.46
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain E: N.355, S.357
- Ligands: NAG.44
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain E: N.361
- Ligands: NAG.44
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain E: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.37
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain E: N.118, S.120, Y.135
Ligand excluded by PLIPNAG.49: 6 residues within 4Å:- Chain E: T.98, Q.100, S.120, N.122, K.131, K.133
Ligand excluded by PLIPNAG.50: 5 residues within 4Å:- Chain E: Q.263, N.265, V.302, S.303, R.412
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain E: N.271, I.292, V.410
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain F: N.100, S.102
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain F: N.107
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain F: E.123, N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Do Kwon, Y. et al., Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat.Struct.Mol.Biol. (2015)
- Release Date
- 2015-06-24
- Peptides
- Envelope glycoprotein gp160: ACE
Envelope glycoprotein gp160: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
GE
GB
BD
BF
B
SMTL ID : 4zmj.1
Crystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimer
Envelope glycoprotein gp160
Toggle Identical (ACE)Envelope glycoprotein gp160
Toggle Identical (BDF)Related Entries With Identical Sequence
4tvp.1 | 5aco.1 | 5c7k.1 | 5cez.2 | 5cjx.1 | 5fyl.1 | 5i8h.1 | 5i8h.2 | 5t3x.1 | 5t3z.1 | 5thr.1 | 5u7m.1 | 5u7o.1 | 5utf.1 | 5uty.1 | 5v7j.1 | 5v8l.1 | 5v8m.1 | 5viy.1 | 5vj6.1 | 5w6d.1 | 6cm3.1 | 6crq.1 | 6de7.1 | 6did.1 | 6mn7.1 | 6mtj.1 | 6mtn.1 | 6mu6.1 | 6mu7.1 more...less...6mu8.1 | 6nf2.1 | 6nm6.1 | 6nnf.1 | 6nnj.1 | 6opa.1 | 6osy.1 | 6ot1.1 | 6oz4.1 | 6ozc.1 | 6pw6.1 | 6u0l.1 | 6u0n.1 | 6udj.1 | 6vi0.1 | 6vn0.1 | 6w03.1 | 6x96.1 | 6x97.1 | 6x98.1 | 6x9r.1 | 6x9r.2 | 6x9r.3 | 6x9s.1 | 6x9s.2 | 6x9s.3 | 6x9t.1 | 6x9t.2 | 6x9t.3 | 6x9u.1 | 6x9u.2 | 6x9u.3 | 6x9v.1 | 6x9v.2 | 6x9v.3 | 6xrt.1 | 7kde.1 | 7lo6.1 | 7lok.1 | 7lpn.1 | 7mxe.1 | 7pc2.1 | 7rai.1 | 7sd3.1 | 7tfn.1 | 7tfo.1 | 7txd.1 | 7ucf.1 | 7uoj.1 | 8dp1.1 | 8dto.1 | 8e1p.1 | 8euu.1 | 8euv.1 | 8euw.1 | 8fis.1 | 8fk5.1 | 8fl1.1 | 8flw.1 | 8fyj.1 | 8g85.1 | 8g9w.1 | 8g9x.1 | 8g9y.1 | 8gas.1 | 8sal.1 | 8san.1 | 8saq.1 | 8sat.1 | 8sav.1 | 8ttw.1